001     302884
005     20250718114121.0
024 7 _ |a 10.1016/j.psychres.2025.116627
|2 doi
024 7 _ |a pmid:40633509
|2 pmid
024 7 _ |a 0925-4927
|2 ISSN
024 7 _ |a 0165-1781
|2 ISSN
024 7 _ |a 1872-7123
|2 ISSN
024 7 _ |a 1872-7506
|2 ISSN
037 _ _ |a DKFZ-2025-01424
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Yang, Jie
|b 0
245 _ _ |a Association between the seroprevalence of infectious pathogens and depression in U.S. adults.
260 _ _ |a Amsterdam
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1752751216_14021
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:C070#
520 _ _ |a There is a paucity of knowledge concerning the relationship between exposure to various pathogens and depression in adults residing in the United States. The objective of the study was to examine the prevalence and severity of depression in populations at risk of viral infections and to investigate the potential association between these two factors.This study was derived from the National Health and Nutrition Examination Survey (NHANES), which included 39,749 participants aged 20 years or older between 2005 and 2018. The Patient Health Questionnaire-9 (PHQ-9) was employed to assess the presence and severity of depressive symptoms. Multivariable logistic regression analyses were conducted to evaluate the odds ratios and associations between viral seropositivity and depression.Significant associations were observed between seropositivity for hepatitis A virus (HAV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), human papillomavirus (HPV) types 6, 11, 16, and 18, and herpes simplex virus (HSV) type 2 and an increased risk of depression (all p-values < 0.05). No significant associations were observed for hepatitis B virus (HBV), hepatitis D virus (HDV), hepatitis E virus (HEV), or HSV type 1.Seropositivity for HPV types 6, 11, 16, and 18, HAV, HCV, HIV, and HSV-2 was significantly associated with depression in a representative sample of U.S. adults.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Depression
|2 Other
650 _ 7 |a Infectious pathogen
|2 Other
650 _ 7 |a Odds ratio
|2 Other
700 1 _ |a Zhong, Qiya
|0 P:(DE-He78)712776690982eb4d6ede991a1eed31b5
|b 1
|u dkfz
700 1 _ |a Peng, Lei
|0 P:(DE-He78)4ce42c81105c13e820996838fed24b31
|b 2
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.psychres.2025.116627
|g Vol. 351, p. 116627 -
|0 PERI:(DE-600)1500675-X
|p 116627
|t Psychiatry research / Neuroimaging
|v 351
|y 2025
|x 0925-4927
909 C O |o oai:inrepo02.dkfz.de:302884
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)712776690982eb4d6ede991a1eed31b5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)4ce42c81105c13e820996838fed24b31
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-25
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PSYCHIAT RES-NEUROIM : 2022
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-25
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1180
|2 StatID
|b Current Contents - Social and Behavioral Sciences
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
|d 2023-08-25
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b PSYCHIAT RES : 2022
|d 2023-08-25
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-25
920 2 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie der Krebsfrüherkennung
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie der Krebsfrüherkennung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21